Results
1 -
10 of
15Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation, Agents and Actions Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents, Agents and Actions Role of corticosterone in modulation of eicosanoid biosynthesis and antiinflammatory activity by 5-lipoxygenase (5-LO) and cyclooxygenase (CO) inhibitors, Agents and Actions Non-steroidal Anti-inflammatory Agents and the Skin, Pharmacology of the Skin II Dermal inflammation in primates, mice, and guinea pigs: Attenuation by second-generation leukotriene B4 receptor antagonist, SC-53228, Inflammation RS-43179: compares well with fluocinolone acetonide in psoriasis, InPharma Psoriasis: an update from Inpharma issue No. 622 30 Jan 1988, InPharma Biochemical and pharmacological properties of a new topical anti-inflammatory compound, 9-phenylnonanohydroxamic acid (BMY 30094), Agents and Actions Histamine release from cord basophils, Agents and Actions Release of Lonapalene from Two-Phase Emulsion-Type Ointment Systems, Pharmaceutical Research